JAMA oncology 2023 Dec 01
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases.
Related Questions
New answer by Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty (July 4, 2024)
Several retrospective studies have shown the good tolerance of concomitant radiotherapy with trastuzumab and pertuzumab either in loco-regional or distant metastatic dise...